Acupuncture, mind-body therapy, and Chinese and Tibetan medicine may relieve pain and other symptoms of RA
RA Treatment Options Expanded with New Infusible TNF Inhibitor
FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)
ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain
With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options
ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies
Rheumatologists offer tips for diagnosing and treating these diseases
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
ACR 2013 State-of-the-Art Clinical Symposium: Diagnosis and Management of Vasculitis
The latest on Behçet’s syndrome, infectious arthritis, and central nervous system vasculitis
New Methodology to Improve Cartilage Repair
A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica
Lyme disease may present the identical clinical picture to PMR and must be ruled out
California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients
A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments
- « Previous Page
- 1
- …
- 293
- 294
- 295
- 296
- 297
- …
- 345
- Next Page »